Custom Antibody Market, 2023

DUBLIN, Jan. 3, 2018 /PRNewswire/ --

The "Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023" report has been added to's offering.

The global custom antibodies market is projected to reach USD 481.2 million by 2023 from USD 313.8 million in 2018, at a CAGR of 8.9% during the forecast period.

Increase in research activities (especially in the life sciences industry), growing industry-academia collaborations, and the expanding antibody therapeutics pipeline are the primary growth drivers for this market. Also, the growing quality concerns over catalog antibodies (to ensure reproducibility of results) is an area of concern in this market, which is primarily why end-users prefer custom-made antibodies.

Rapid growth in developing countries across APAC and Latin America, the increasing demand for personalized medicine and protein therapeutics, growth in stem cell and neurobiology research, and the clinical significance of biomarker discovery are expected to offer significant growth opportunities for market players during the forecast period. On the other hand, the need for steep capital investments and long duration of antibody development, along with the increasing focus on antibody alternatives for proteomic studies, are some of the major market challenges.

The custom antibodies market is highly competitive, with a number of players competing for a larger market share. The prominent players in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Abcam plc (UK), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), GenScript (US), BioLegend, Inc. (US), Rockland Immunochemcials, Inc. (US), ProMab Biotechnologies (US), Innovagen AB (Sweden), and ProteoGenix (US).

Due to the intense competition in this market, major market players are increasingly focusing on expanding their geographic presence in the high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players.

Key Topics Covered:

1 Custom Antibody Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Stakeholders
1.6 Limitations

2 Custom Antibody Market: Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Custom Antibody Market: Executive Summary

4 Custom Antibody Market: Premium Insights
4.1 Custom Antibodies Market: Overview
4.2 Custom Antibodies Market: Geographic Growth Opportunities
4.3 Regional Mix: Custom Antibodies Market (2018-2023)
4.4 Custom Antibodies Market: Developed vs Developing Markets, 2018 vs 2023

5 Custom Antibody Market: Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers Increasing Research Activity and Funding Quality Concerns Over Catalog Antibodies Increasing Antibody Therapeutics and Expanding Drug Pipeline Growing Industry-Academia Collaborations
5.2.2 Market Opportunities High Growth Opportunities in Emerging Countries Increasing Demand for Personalized Medicine and Protein Therapeutics Growth in Stem Cell and Cvd Research Increasing Focus on Biomarker Discovery
5.2.3 Market Challenges Cost- and Time-Intensive Antibody Development Processes Presence of Antibody Alternatives
5.2.4 Industry Trends Increasing Focus on Antibody-Drug Conjugates (ADCS) Development of Bispecific Antibodies

6 Custom Antibody Market, By Service
6.1 Introduction
6.2 Antibody Development
6.2.1 Antibody Characterization Characterization Eliminates Antibodies With Heterogeneities That May Hamper Research Studies; This is Driving Market Growth
6.2.2 Antigen Preparation Antigen Preparation Forms One of the Most Important Steps in the Antibody Production Process
6.2.3 Immunization & Hybridoma Production Specific Immunization Protocols are Followed Depending on the Antibody Required and Animal Used to Generate Them
6.3 Antibody Production & Purification
6.4 Antibody Fragmentation & Labeling

7 Custom Antibody Market, By Type
7.1 Introduction
7.2 Monoclonal Antibodies
7.2.1 Monoclonal Antibodies to Dominate the Market During the Forecast Period
7.3 Polyclonal Antibodies
7.3.1 Polyclonal Abs are Preferred in Proteomic Research for Detection of Denatured Proteins
7.4 Recombinant Antibodies
7.4.1 Research Reproducibility Offered By These Antibodies is Driving the Growth of the Recombinant Antibodies Segment
7.5 Other Custom Antibodies

8 Custom Antibody Market, By Source
8.1 Introduction
8.2 Mice
8.2.1 Mice are the Most Preferred Hosts for Monoclonal Antibody Production
8.3 Rabbits
8.3.1 Antibodies Developed in Rabbits Eliminate the Limitation of Self-Antigen Recognition in Humans
8.4 Other Sources

9 Custom Antibody Market, By Research Area
9.1 Introduction
9.2 Oncology
9.2.1 Use of Antibodies has Grown Considerably in Cancer Research
9.3 Infectious Diseases
9.3.1 Antibodies are Widely Used in R&D for the Development of Vaccines & Therapeutics Against Various Infectious Diseases
9.4 Immunology
9.4.1 Assessment of Cell Surface Antigens Using Antibodies Forms an Important Field of Research in Immunology
9.5 Neurobiology
9.5.1 Neurobiology Forms One of the Fastest-Growing Segments in Terms of Research Being Undertaken Utilizing Antibodies
9.6 Stem Cells
9.6.1 Availability of High-Quality Antibodies has Boosted Stem Cell Research
9.7 Cardiovascular Diseases
9.7.1 Identification & Characterization of Cvd Biomarkers is an Important Research Area Utilizing Antibodies
9.8 Other Research Areas

10 Custom Antibody Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Pharmaceutical & Biotechnology Companies are the Largest End Users of Custom Antibodies
10.3 Academic & Research Institutes
10.3.1 Increase in DNA Sequencing Studies and Proteomic Research to Drive Market Growth
10.4 Contract Research Organizations
10.4.1 Cros Provide Affordable Outlets for Companies and Academia to Pursue New Medicines and Offer A Cost-Effective Solution to Develop Drugs

11 Custom Antibody Market, By Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 Latin America
11.6 Middle East & Africa

12 Custom Antibody Market: Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product & Services Launches
12.3.2 Expansions
12.3.3 Acquisitions
12.3.4 Other Strategies

13 Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.2 Genscript
13.3 Abcam PLC
13.4 Merck Group
13.5 Bio-Rad Laboratories, Inc.
13.6 Cell Signaling Technology, Inc.
13.7 Agilent Technologies, Inc.
13.8 Biolegend, Inc.
13.9 Rockland Immunochemicals Inc.
13.10 Promab Biotechnologies, Inc.
13.11 Proteogenix
13.12 Innovagen Ab

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets